De novo assembly of nuclear stress bodies rearranges and enhances NFIL3 to restrain acute inflammatory responses.

Summary

This study demonstrates that nuclear stress bodies orchestrate chromatin reorganization to upregulate NFIL3, suppressing proinflammatory cytokines. In patient samples, SatIII activation and NFIL3 expression correlate with survival in sepsis, linking chromatin architecture to clinically relevant immunoregulation.

Key Findings

• Stress-induced nSBs assemble from SatIII DNAs/RNAs and ~30 proteins, expanding SatIII loci and enhancing adjacent gene expression including NFIL3.
• NFIL3 loci repositioning within nSBs increases chromatin accessibility and recruitment of HSF1 and BRD4 to NFIL3 promoters.
• PBMC-derived macrophages show increased SatIII and NFIL3 with reduced inflammatory cytokines after heat shock plus PAMP stimulation.
• In septic patients, NFIL3 expression positively correlates with SatIII activation and survival.

Clinical Implications

NFIL3 and SatIII activation could serve as biomarkers of immune restraint in sepsis, and pharmacologic modulation of nSB components (e.g., HSF1/BRD4 interactions) may represent future immunoregulatory strategies.

Limitations

• Causality in human sepsis was inferred by correlation; interventional validation in vivo is lacking.
• Primates-specific SatIII/nSB biology may limit generalizability across species.

Future Directions

Test pharmacologic or genetic modulation of the nSB–NFIL3 axis in preclinical sepsis models and evaluate NFIL3/SatIII as prognostic biomarkers in prospective cohorts.